Table 1.
Clinicopathology characteristics of patients
| Variable | N | % |
|---|---|---|
| All | 147 | 100.0 |
| T-stage | ||
| 1 | 105 | 71.4 |
| > 1 | 42 | 28.6 |
| N-stage | ||
| 0 | 93 | 63.3 |
| > 1 | 53 | 36.1 |
| Grade | ||
| 1 and 2 | 89 | 60.5 |
| 3 | 56 | 38.1 |
| Histology | ||
| Invasive ductal carcinoma | 127 | 86.4 |
| Other | 20 | 13.6 |
| Hormone receptor status | ||
| Negative for both | 13 | 8.8 |
| Positive for either | 134 | 91.2 |
| HER2/neu status | ||
| Negative | 126 | 85.7 |
| Positive | 21 | 14.3 |
| Ki 67 (cut-off 14 %) | ||
| Low | 85 | 57.8 |
| High | 62 | 42.2 |
| Molecular subtype | ||
| Luminal A | 85 | 57.8 |
| Luminal B | 30 | 20.4 |
| HER2/neu positive | 21 | 14.3 |
| Triple negative | 11 | 7.5 |
| CTC_EP | ||
| Present | 20 | 13.6 |
| Absent | 127 | 86.4 |
| CTC_EMT | ||
| Present | 20 | 13.6 |
| Absent | 127 | 86.4 |
| Any CTC | ||
| Present | 37 | 25.2 |
| Absent | 110 | 74.8 |